Ignite Creation Date:
2024-05-06 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 2:32 PM
Study NCT ID:
NCT05363111
Status:
RECRUITING
Last Update Posted:
2024-01-25
First Post:
2022-05-03
Brief Title:
Radioimmunotherapy 111Indium225Actinium-DOTA-daratumumab for the Treatment of RelapsedRefractory Multiple Myeloma
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-22
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-22
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-03
First Submit QC Date:
May 3 2022
Study First Post Date:
2022-05-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-24
Last Update Post Date:
2024-01-25
Last Update Post Date Type:
ACTUAL